Search

Eye testing at home – developing an app for measuring vision

COVID-19 has made home vision monitoring a necessity. Stephanie Campbell shares how her idea for a vision testing app that would engage patients became a reality. Months before COVID-19 first began to mutate to its human host, there was a...

Getting one’s eye in

Lisette Bijma, Sister in the Eye Emergency Department at John Radcliffe Hospital, explains how COVID-19 provided a ‘baptism by fire’ and enabled fundamental and positive changes to the running of the department. Five years ago, I arrived in the UK,...

The Ophthalmic Imaging Association holds successful first virtual conference

When the coronavirus pandemic hit, many of the things we enjoy were postponed or cancelled, including the 2020 Ophthalmic Imaging Association (OIA) conference. The Ophthalmic Imaging Association committee began focusing on 2021 but it soon became apparent a face-to-face conference...

In conversation with Clare Abbott (ECLO)

Rosalyn Painter spoke to Clare Abbott, a member of the Eye Clinic Liaison Officer (ECLO) team at Oxford Eye Hospital, about her day-to-day job as an ECLO, how the role can help patients, and the ongoing importance of their work....

Low vision support in teenagers

As society places increasing emphasis on mental health and access to technology increases, the structure and prioritisation within low vision appointments is evolving. These changes bring new challenges and demands in terms of our clinical support, requiring us to consider...

Diabetes and diabetic retinopathy: Changes in understanding of the disease over the last 25 years and how the UK is helping low-income countries tackle the challenges

Diabetes – a historical perspective Diabetes mellitus (DM) is a chronic disease caused by inherited and / or acquired deficiency in production of insulin by the pancreas, or by the ineffectiveness of the insulin produced. Such a deficiency results in...

Strategies for managing neovascular AMD and DMO in routine clinical care

Treatment practice in the management of neovascular age-related macular degeneration (AMD) and diabetic macular oedema (DMO) illustrate increasing adoption of patient-tailored treatment approaches based on initial diagnosis and regular monitoring of imaging and visual outcomes in routine clinical care. The...

Rare eye diseases: progress continues with authorised orphan medicines and breakthrough technologies

An update on the development of orphan medicines, recent regulatory treatment approvals for rare eye conditions and advances in retinal prosthetic technologies for blinding diseases. The prevalence of a rare disease is based usually on a range of estimates and...